Avoro Capital Advisors as of Dec. 31, 2019
Portfolio Holdings for Avoro Capital Advisors
Avoro Capital Advisors holds 30 positions in its portfolio as reported in the December 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 15.3 | $518M | 25M | 21.16 | |
| Mirati Therapeutics | 14.7 | $496M | 3.9M | 128.86 | |
| Ascendis Pharma A S (ASND) | 7.7 | $260M | 1.9M | 139.12 | |
| Iovance Biotherapeutics (IOVA) | 7.2 | $244M | 8.8M | 27.68 | |
| Sarepta Therapeutics (SRPT) | 6.7 | $227M | 1.8M | 129.04 | |
| Constellation Pharmceticls I | 5.1 | $172M | 3.7M | 47.11 | |
| BioMarin Pharmaceutical (BMRN) | 5.0 | $169M | 2.0M | 84.55 | |
| Argenx Se (ARGX) | 4.4 | $150M | 937k | 160.52 | |
| Horizon Therapeutics | 4.3 | $145M | 4.0M | 36.20 | |
| Uniqure Nv (QURE) | 3.6 | $122M | 1.7M | 71.66 | |
| Karyopharm Therapeutics (KPTI) | 3.3 | $113M | 5.9M | 19.17 | |
| Myokardia | 3.3 | $112M | 1.5M | 72.89 | |
| Amicus Therapeutics (FOLD) | 3.2 | $109M | 11M | 9.74 | |
| Zogenix | 3.1 | $104M | 2.0M | 52.13 | |
| Athenex | 2.4 | $80M | 5.3M | 15.27 | |
| Adverum Biotechnologies | 1.8 | $61M | 5.3M | 11.52 | |
| Tricida | 1.7 | $59M | 1.6M | 37.74 | |
| Amarin Corporation (AMRN) | 1.2 | $41M | 1.9M | 21.44 | |
| Madrigal Pharmaceuticals (MDGL) | 0.9 | $32M | 349k | 91.11 | |
| Xenon Pharmaceuticals (XENE) | 0.9 | $32M | 2.4M | 13.11 | |
| Cue Biopharma (CUE) | 0.9 | $30M | 1.9M | 15.87 | |
| Allogene Therapeutics (ALLO) | 0.9 | $29M | 1.1M | 25.98 | |
| BioDelivery Sciences International | 0.6 | $19M | 3.0M | 6.32 | |
| Deciphera Pharmaceuticals | 0.5 | $17M | 1.3M | 13.20 | |
| Marinus Pharmaceuticals | 0.4 | $13M | 6.2M | 2.16 | |
| Tg Therapeutics (TGTX) | 0.3 | $11M | 1.0M | 11.10 | |
| Cymabay Therapeutics | 0.3 | $11M | 5.5M | 1.96 | |
| Fennec Pharmaceuticals (FENC) | 0.2 | $7.2M | 1.1M | 6.48 | |
| Alimera Sciences | 0.1 | $3.2M | 416k | 7.58 | |
| Seattle Genetics | 0.0 | $150k | 75k | 2.00 |
